Fundraising FoxAzafaros
Leiden, NL · 12 known investors
Find your way into Azafaros
Sign up to see every warm intro you have to Azafaros
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Azafaros team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Azafaros is a clinical-stage biopharmaceutical company developing small-molecule therapies for severe rare genetic metabolic disorders, including GM1/GM2 gangliosidoses, Niemann-Pick type C disease, and other conditions. The company's lead program, nizubaglustat, is currently in Phase 3 trials.
Founders & leadership
Investors · 12
How we know: the company's own site · BioGeneration Ventures's portfolio page · a partner's Signal profile · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: BioMedPartners's portfolio page · the company's own site · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Forbion's portfolio page · the company's own site · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the company's own site · funding news · biospace.com · Not right? Tell us
How we know: the company's own site · siliconcanals.com · Not right? Tell us
Also in the syndicate · 5
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BMay 2025 · 5 sources
Forbion Growth (lead), Jeito Capital (lead), BioGeneration Ventures (BGV), Forbion Ventures, Pictet Group, Schroders Capital, Seroba
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Related companies · 1
Companies working in the same space as Azafaros.
In the news
Frequently asked questions
- What does Azafaros do?
- Azafaros is a clinical-stage biopharmaceutical company developing small-molecule therapies for severe rare genetic metabolic disorders, including GM1/GM2 gangliosidoses, Niemann-Pick type C disease, and other conditions. The company's lead program, nizubaglustat, is currently in Phase 3 trials.
- Who founded Azafaros?
- Azafaros was founded by Hans Aerts, Hermen Overkleeft, Stan van Boeckel.
- Who are Azafaros's investors?
- Azafaros's investors include BioGeneration Ventures, BioMedPartners, Forbion, Jeito Capital, Pictet Group, Asahi Kasei Corporate Venture Capital, Seroba Life Sciences.
- Where is Azafaros headquartered?
- Azafaros is headquartered in Leiden, NL.